We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Tecan Brings HP Direct Digital Titration to Drug Discovery Biologists

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Tecan has announced the commercial availability of the new HP D300 Digital Dispenser, a simple, standalone instrument for the pharmaceutical sector, which uses HP Direct Digital Dispensing technology to rapidly deliver picoliter to microliter volumes of drug compounds.

Available exclusively through Tecan, this innovative device can cut titration times from hours or days to just minutes.

Based on HP inkjet technology, the Digital Dispenser is the result of an agreement between Tecan and HP to commercialize this new technology for use in drug discovery research.

The HP D300 provides fast and reliable performance across a large dynamic range, eliminating the need for slow, error-prone and wasteful serial dilutions.

Using disposable dispense heads to help avoid the possibility of cross-contamination, the instrument offers non-contact digital dispensing from 13 pl to 5 μl, delivering any dose to any well and virtually eliminating waste of valuable compounds.

It combines walk up convenience, ready-to-run performance and flexible, intuitive experiment design software to increase research productivity, reliability of results and the speed of drug discovery workflows.

Wendy Lauber, Head Product Management for Liquid Handling and Consumables at Tecan, commented: “The pharmaceutical industry is recognizing a need for change, and there is a growing trend towards benchtop automation solutions. New technologies such as Direct Digital Titration can offer fresh solutions to entrenched challenges, helping to improve productivity and accelerate the discovery of better drugs.”